Babies can be born with cancer that developed in the mother’s womb. One such cancer is a disease with a long name: infantile myofibromatosis (IM).

The US Food and Drug Administration has approved a medication to treat gastrointestinal stromal tumors (GIST) that can’t be removed with surgery, have spread or no longer respond to existing therapies.